Doctor's Notes

Four Cold-Strain Conditions in 10 Male Cyclists

Fictional adult active-life illustration for Four Cold-Strain Conditions in 10 Male Cyclists; faithful Dr. Arsy #003 jar; study did not test product

Evidence note: the lifestyle scene is a fictional AI-assisted illustration. It does not depict a study participant, clinician endorsement, diagnosis, or before/after result.

Why this active-life question matters

Ten men completed randomized crossover cycling after thermoneutral exposure, skin cooling or two levels of mild core cooling. The practical value is not a promise that one routine or product works for everyone. It is a closer look at how a specific exposure was measured, which comparison was made, and how much uncertainty remains.

Busy adults move between climate-controlled rooms, protective equipment, repeated washing, exercise, footwear and bathing. Those settings can change surface water, temperature, occlusion and measurement conditions. A reading such as transepidermal water loss is useful only when the anatomical site, acclimation, environment and timing are kept in view.

Study snapshot

Evidence element What the paper reports
Population and design Ten men completed randomized crossover cycling after thermoneutral exposure, skin cooling or two levels of mild core cooling.
Comparator Thermoneutral, cold shell, −0.5°C core change and −1.0°C core change
Timepoint/exposure Cycling at 70% peak power until exhaustion
Numerical result Time to exhaustion was 23.75±13.75, 16.22±10.30, 8.50±5.23 and 6.50±5.60 minutes, respectively (condition P≤0.001).
Important limitation Small all-male laboratory protocol in 0°C air; exhaustion time does not define individual cold-exposure safety limits.
Funding 2018-04077 / Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC)
Conflicts Not reported in the PubMed record.

What the investigators actually did

We tested the effects of cold air (0°C) exposure on endurance capacity to different levels of cold strain ranging from skin cooling to core cooling of Δ-1.0°C. Ten males completed a randomized, crossover, control study consisting of a cycling time to exhaustion (TTE) at 70% of their peak power output following: 1) 30-min of exposure to 22°C thermoneutral air (TN), 2) 30-min exposure to 0°C air leading to a cold shell (CS), 3) 0°C air exposure causing mild hypothermia of -0.5°C from baseline rectal temperature (HYPO-0.5°C), and 4) 0°C air exposure causing mild hypothermia of -1.0°C from baseline rectal temperature (HYPO-1.0°C). The latter three conditions tested TTE in 0°C air. Core temperature and seven-site mean skin temperature at the start of the TTE were: TN (37.0 ± 0.2°C, 31.2 ± 0.8°C), CS (37.1 ± 0.3°C, 25.5 ± 1.4°C), HYPO-0.5°C (36.6 ± 0.4°C, 22.3 ± 2.2°C), HYPO-1.0°C (36.4 ± 0.5°C, 21.4 ± 2.7°C). There was a significant condition effect (P ≤ 0.001) for TTE, which from TN (23.75 ± 13.75 min) to CS (16.22 ± 10.30 min, Δ-30.9 ± 21.5%, P = 0.055), HYPO-0.5°C (8.50 ± 5.23 min, Δ-61.4 ± 19.7%, P ≤ 0.001), and HYPO-1.0°C (6.50 ± 5.60 min, Δ-71.6 ± 16.4%, P ≤ 0.001). Furthermore, participants had a greater endurance capacity in CS compared with HYPO-0.5°C (P = 0.046), and HYPO-1.0°C (P = 0.007), with no differences between HYPO-0.5°C and HYPO-1.0°C (P = 1.00). Endurance capacity impairment at 70% peak power output occurs early in cold exposure with skin cooling, with significantly larger impairments with mild hypothermia up to Δ-1.0°C.NEW & NOTEWORTHY We developed a novel protocol that cooled skin temperature, or skin plus core temperature (Δ-0.5°C or Δ-1.0 °C), to determine a dose-response of cold exposure on endurance capacity at 70% peak power output. Skin cooling significantly impaired exercise tolerance time by ∼31%, whereas core cooling led to a further reduction of 30%-40% with no difference between Δ-0.5°C and Δ-1.0°C. Overall, simply cooling the skin impaired endurance capacity, but this impairment is further magnified by core cooling.

How to read the result without overreaching

Time to exhaustion was 23.75±13.75, 16.22±10.30, 8.50±5.23 and 6.50±5.60 minutes, respectively (condition P≤0.001). This finding belongs to the cited design, population and timepoint. It should not be converted into a diagnosis, a universal rule, or proof that a cosmetic moisturizer prevents or treats disease.

Small all-male laboratory protocol in 0°C air; exhaustion time does not define individual cold-exposure safety limits. The result may still help readers notice which parts of daily life deserve attention: exposure duration, recovery time, anatomical site, product or material formulation, and whether the comparison was randomized, observational or within-person.

Questions the paper can—and cannot—answer

The paper can describe the measurements made under its stated conditions and the uncertainty visible in its design. It cannot establish that every adult will respond the same way, that a different fabric or formula will behave identically, or that a short instrumental change equals a meaningful health outcome. Numerical readings also depend on calibration, room conditions, acclimation, body site and timing.

For practical decisions, the most defensible takeaway is to separate exposure management from cosmetic care. Adjusting friction, heat, moisture, glove or clothing practices may be relevant to the activity itself. A moisturizer has a narrower role: supporting hydration, the moisture barrier and dry-skin comfort. Persistent or worsening symptoms require individualized clinical evaluation rather than extrapolation from this study.

Practical, claim-safe routine thinking

  • Use the gentlest routine that fits the task and workplace rules.
  • After washing, dry carefully and pay attention to repeated friction, heat and occlusion.
  • For persistent cracking, rash, swelling, pain, drainage or infection concerns, seek qualified medical care.
  • Do not assume that results from a study formulation, device, sock, cleanser, glove or shower system apply to a different product.

Where Dr. Arsy #003 fits—and where it does not

Dr. Arsy #003 is a cosmetic face-and-body moisturizer for hydration, moisture-barrier support and dry-skin comfort. It was not tested in the cited study, and the study’s outcomes are not being transferred to #003. This article does not claim treatment, cure, prevention, itch or pain relief, universal tolerance, pediatric safety, or 24-hour protection.

View Dr. Arsy #003 Moisturizer

Continue reading

Primary and authoritative sources

PubMed indexing identifies a bibliographic record; it is not NIH endorsement.

← Back to Doctor's Notes